NASDAQ:CODX   Co-Diagnostics, Inc.
Although CODX has Earnings Tomorrow I am Writing Long Term CODX has been involved with COVID testing from the jump start. If you want to place a long trade after tomorrow's announcement that would be ok also. I already have my long calls.


The Mexican Department of Epidemiology has approved for sale a COVID-19 diagnostic test manufactured by Co-Diagnostics (NASDAQ: CODX). In addition, CoSara, a joint venture that the molecular diagnostics company formed in India, has also been cleared to sell test kits in the world's second-most populous country. The Centers for Medicare and Medicaid Services (CMS), which regulates all U.S. laboratory testing performed on humans, has also approved the sale of the test to roughly 260,000 clinical laboratories across the country.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.